Stocks Health care LFWD
NASDAQ · Health careLifeward Ltd. (LFWD)
Lifeward Ltd. brought in $21.8M of revenue over the twelve months to June 30, 2026, down 10.7% from a year earlier. It posted a net loss of $30.8M. In fiscal 2025 capital spending exceeded operating cash flow by $16.8M. At June 30, 2026 it held $9.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch LFWD in 60 secondsWhat Lifeward Ltd. does
Lifeward Ltd. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker LFWD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $22M | -$19.9M | -$17.16 | -$16.8M |
| 2024 | $25.7M | -$28.9M | -$39.96 | -$21.7M |
| 2023 | $13.9M | -$22.1M | -$31.13 | -$20.7M |
| 2022 | $5.5M | -$19.6M | -$26.44 | -$17.9M |
| 2021 | $6M | -$12.7M | -$23.03 | -$11.5M |
| 2020 | $4.4M | -$13M | -$69.94 | -$12.7M |
Full financial statements: income, balance sheet and cash flow
Where LFWD ranks in Health care
Latest SEC filings
What Lifeward Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026
- September 25, 2026Proxy statement DEF 14A
- September 15, 2026Preliminary proxy statement PRE 14A
- September 15, 2026
- September 8, 2026
- August 31, 2026
- August 20, 2026
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 16% to $6.6M versus the same quarter last year; diluted EPS -$4.12 versus -$7.01.
- August 14, 2026
- August 3, 2026
Insider trades
What the people running Lifeward Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 20, 2026 | Gabay AvrahamDirector | Received as pay | 13,643 | - |
| August 14, 2026 | Zamir HaggaiDirector | Received as pay | 6,711 | - |
| August 14, 2026 | Greenwald YonasonDirector | Received as pay | 6,711 | - |
| May 1, 2026 | Rose Keith DaleChief Medical Officer | Received as pay | 15,000 | - |
Who owns LFWD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
4 insiders reported holding 44,148 shares in total, about $308.6K at the last price.
| Holder | Shares |
|---|---|
| Rose Keith DaleChief Medical Officer | 17,083 |
| Gabay AvrahamDirector | 13,643 |
| Greenwald YonasonDirector | 6,711 |
| Zamir HaggaiDirector | 6,711 |
Questions about LFWD
What does Lifeward Ltd. do?
Lifeward Ltd. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker LFWD.
Is Lifeward Ltd. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $30.8M on revenue of $21.8M.
How much revenue does Lifeward Ltd. make?
Over the twelve months to June 30, 2026 Lifeward Ltd. reported revenue of $21.8M. That is 10.7% less than a year earlier.
When did Lifeward Ltd. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the annual report to shareholders from September 25, 2026.
Similar companies
Compare LFWD with
Follow LFWD
Get an email when Lifeward Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow LFWD: get an email when it filesWhere the numbers come from
Financial figures are the values Lifeward Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.